netilmicin
CLINICAL USE
Antibacterial agent
DOSE IN NORMAL RENAL FUNCTION
IM, IV: 4–7.5 mg/kg daily, as a single daily dose or in divided doses every 8 or 12 hoursUrinary tract infection: 150 mg daily for 5 days
PHARMACOKINETICS
Molecular weight                           :1441.6 (as sulphate) %Protein binding                           :<5 %Excreted unchanged in urine     : 80 Volume of distribution (L/kg)       :0.16–0.3half-life – normal/ESRD (hrs)      :2–2.5/35–72 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : 4–7.5 mg/kg once daily. Monitor levels 10 to 20     : 3–4 mg/kg once daily. Monitor levels <10           : 2 mg/kg once daily. Monitor levels DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Dialysed. IV: 2 mg/kg on alternate daysIP: 7.5–10 mg/L per exchange. Monitor levels HD                     :Dialysed. Administer 2 mg/kg at the end of each dialysis session. Monitor levelsHDF/high flux   :Dialysed. Administer 2 mg/kg at the end of each dialysis session. Monitor levelsCAV/VVHD      :Dialysed. Dose as in GFR=10–20 mL/min. Monitor levels IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsBotulinum toxin: neuromuscular block enhanced (risk of toxicity)Ciclosporin: increased risk of nephrotoxicityCytotoxics: increased risk of nephrotoxicity and possibly of ototoxicity with platinum compounds Diuretics: increased risk of ototoxicity with loop diureticsMuscle relaxants: effects of non- depolarising muscle relaxants and suxamethonium enhancedParasympathomimetics: antagonism of effect of neostigmine and pyridostigmine Tacrolimus: increased risk of nephrotoxicity ADMINISTRATION
Reconstition
– Route
IM, IP, IV bolus or infusion Rate of Administration
IV bolus: Administer over 3–5 minutes IV infusion
: Administer over 0.5–2 hours Comments
Add to 50–200 mL of sterile water for injection, sodium chloride 0.9%, glucose 5% or 10%IM and IV dose are identical. Calculate on mg/kg lean body weight, or actual weight, whichever is lower OTHER INFORMATION
Netilmicin serum concentrations should be monitored and used for basis of dosage adjustment, otherwise follow guidelines in the SPC according to serum creatinine/creatinine clearanceOnce-daily administration of netilmicin may lead to transient peak concentrations of 20–30 micrograms/mL. Other dosage regimens will result in peak levels not exceeding 12 micrograms/mL. Prolonged levels above 16 micrograms/mL should be avoided. If trough levels are monitored they will usually be 3 micrograms/mL or less with the recommended dosage. Increasing trough concentrations above 4 micrograms/mL should be avoided.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home